• 
  Adrien Breiman, Nathalie Ruvoën-Clouet, Marie Deleers, Tiffany Beauvais, Nicolas Jouand, et al.. Low levels of natural anti-a-N-acetylgalactosamine (Tn) antibodies are associated with COVID-19. Frontiers in Microbiology, Frontiers Media, 2021, Online ahead of print. ⟨inserm-03122540⟩
• 
  Jacques Pendu, Adrien Breiman, Jézabel Rocher, Michel Dion, Nathalie Ruvoën-Clouet. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses, MDPI, 2021, 13 (2), pp.160. ⟨10.3390/v13020160⟩. ⟨inserm-03122495⟩
• 
  M Foulon, M Robbe-Saule, J Manry, L Esnault, Y Boucaud, et al.. Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology. PLoS Pathogens, Public Library of Science, 2020, 16 (12), pp.e1009107. ⟨10.1371/journal.ppat.1009107⟩. ⟨inserm-03113905⟩
• 
  Amelie Decourcelle, Ninon Very, Madjid Djouina, Ingrid Loison, Julien Thevenet, et al.. O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis. Cancers, MDPI, 2020, Cancers, 12 (11), pp.3168. ⟨10.3390/cancers12113168⟩. ⟨hal-03110218⟩
• 
  Judith Delage, Alain Faivre-Chauvet, Jacques Barbet, Julie Fierle, Niklaus Schaefer, et al.. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model. Pharmaceutics, MDPI, 2021, 13 (96), Online ahead of print. ⟨10.3390/pharmaceutics13010096⟩. ⟨inserm-03109836⟩
• 
  Yanna-Marina Chevalme, Lotfi Boudali, Mathieu Gauthé, Caroline Rousseau, Andrea Skanjeti, et al.. Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, Online ahead of print. ⟨10.1007/s00259-020-05086-1⟩. ⟨inserm-03109828⟩
• 
  Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz-Knoll, Michele Iuliani, et al.. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene, Nature Publishing Group, In press, ⟨10.1038/s41388-020-01603-6⟩. ⟨hal-03104932⟩
• 
  Shima Ghoroghi, Benjamin Mary, Annabel Larnicol, Nandini Asokan, Annick Klein, et al.. Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. eLife, eLife Sciences Publication, 2021, pp.e61539. ⟨10.7554/eLife.61539⟩. ⟨inserm-03103515⟩
• 
  Philippe Clézardin, Rob Coleman, Margherita Puppo, Penelope Ottewell, Edith Bonnelye, et al.. Bone Metastasis: Mechanisms, Therapies and Biomarkers. Physiological Reviews, American Physiological Society, In press, ⟨10.1152/physrev.00012.2019⟩. ⟨hal-03102895⟩
• 
  Edith Bonnelye. Estrogen Receptor Related Receptor Alpha (ERRα) in Skeletal Tissues. Endocrinology & Metabolic Syndrome, 2016, 5 (4), ⟨10.4172/2161-1017.1000244⟩. ⟨hal-03100891⟩

672